Last 12 months
Inside the activity.
2 purchase rows · 31 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 16 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 2 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 25, 2026 20:05 UTC |
Burrows FrancisChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $6.15 | $0.00 |
DisclosureSEC source: 0001193125-26-402815 · ownership.xml · derivative · entry 3 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common stock · 30,000 shares Expires 2027-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option is fully vested. Read SEC document |
| September 24, 2026 Filed Sep 25, 2026 20:05 UTC |
Burrows FrancisChief Scientific Officer
|
SaleCommon Stock | 20,726 | $10.83 | $224,514.40 |
DisclosureSEC source: 0001193125-26-402815 · ownership.xml · nonDerivative · entry 2 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,327 F3 · price: This transaction was executed in multiple trades at prices ranging from $10.82 to $10.85. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| September 24, 2026 Filed Sep 25, 2026 20:05 UTC |
Burrows FrancisChief Scientific Officer
|
Exercise / conversionCommon Stock | 30,000 | $6.15 | $184,500.00 |
DisclosureSEC source: 0001193125-26-402815 · ownership.xml · nonDerivative · entry 1 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,053 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Cashless exercise and sale of a portion of a stock option to cover estimated payroll tax liability. F2 · balance_after: Includes 629 shares acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| September 08, 2026 Filed Sep 10, 2026 20:30 UTC |
Fulk JenniferChief Financial Officer
|
GrantOption to purchase common stock · Derivative | 450,000 | $0.00 Strike: $12.52 | $0.00 |
DisclosureSEC source: 0001193125-26-387934 · ownership.xml · derivative · entry 1 Fulk Jennifer · CIK 0001873522 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 450,000 Underlying: Common Stock · 450,000 shares Expires 2036-09-07 F1 · derivative.exercise_date: 1/4th of the shares vest on the one year anniversary of the vesting commencement date, and 1/48th of the shares vest in 36 monthly installments thereafter. Read SEC document |
| August 24, 2026 Filed Aug 24, 2026 21:30 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
PurchaseCommon Stock | 100,000 | $12.39 | $1,239,000.00 |
DisclosureSEC source: 0001193125-26-363812 · ownership.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by One Fish Two Fish Revocable Trust Disclosed balance after: 479,194 F1 · price: This transaction was executed in multiple trades at prices ranging from $11.47 to $12.85. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 21, 2026 Filed Aug 24, 2026 21:30 UTC |
Powl Brian T.Chief Commercial Officer
|
SaleCommon Stock | 4,345 | $11.89 | $51,663.35 |
DisclosureSEC source: 0001193125-26-363810 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 169,269 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025. F2 · price: This transaction was executed in multiple trades at prices ranging from $11.78 to $12.00. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 20:30 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 31,487 | $12.63 | $397,680.81 |
DisclosureSEC source: 0001193125-26-361184 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 195,444 F1 · kind: The shares sold were acquired by the Reporting Person upon vesting of restricted stock units during the period from January 26, 2024 through January 26, 2026. The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 20, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $12.44 to $12.83. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 17, 2026 Filed Aug 17, 2026 20:45 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
PurchaseCommon Stock | 100,000 | $11.12 | $1,112,000.00 |
DisclosureSEC source: 0001193125-26-354201 · ownership.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Indirect · by One Fish Two Fish Revocable Trust Disclosed balance after: 379,194 F1 · price: This transaction was executed in multiple trades at prices ranging from $10.87 to $11.31. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 18, 2026 Filed Jun 22, 2026 22:00 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 84,929 | $9.82 | $834,283.05 |
DisclosureSEC source: 0001193125-26-277780 · ownership.xml · nonDerivative · entry 1 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 182,345 F1 · kind: The shares sold were acquired by the Reporting Person upon vesting of restricted stock units and performance restricted stock units during the period from January 26, 2022 through January 26, 2026. The sales reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2026. F2 · price: This transaction was executed in multiple trades at prices ranging from $9.56 to $9.98. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| June 04, 2026 Filed Jun 4, 2026 22:30 UTC |
Parks Diane L.Director
|
GrantOption to purchase common stock · Derivative | 35,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001193125-26-257903 · ownership.xml · derivative · entry 1 Parks Diane L. · CIK 0001781026 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2036-06-03 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 04, 2026 Filed Jun 4, 2026 22:30 UTC |
VASCONCELLES MICHAELDirector
|
GrantOption to purchase common stock · Derivative | 35,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001193125-26-257902 · ownership.xml · derivative · entry 1 VASCONCELLES MICHAEL · CIK 0001734755 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2036-06-03 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 04, 2026 Filed Jun 4, 2026 22:30 UTC |
Hasnain FaheemDirector
|
GrantOption to purchase common stock · Derivative | 35,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001193125-26-257901 · ownership.xml · derivative · entry 1 Hasnain Faheem · CIK 0001352620 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2036-06-03 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 04, 2026 Filed Jun 4, 2026 22:30 UTC |
Collins Helen LouiseDirector
|
GrantOption to purchase common stock · Derivative | 35,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001193125-26-257900 · ownership.xml · derivative · entry 1 Collins Helen Louise · CIK 0001701247 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2036-06-03 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 04, 2026 Filed Jun 4, 2026 22:30 UTC |
SCHAFER CAROLDirector
|
GrantOption to purchase common stock · Derivative | 35,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001193125-26-257898 · ownership.xml · derivative · entry 1 SCHAFER CAROL · CIK 0001272181 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2036-06-03 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 04, 2026 Filed Jun 4, 2026 22:30 UTC |
Szela Mary TDirector
|
GrantOption to purchase common stock · Derivative | 35,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001193125-26-257897 · ownership.xml · derivative · entry 1 Szela Mary T · CIK 0001410289 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2036-06-03 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| June 04, 2026 Filed Jun 4, 2026 22:30 UTC |
Malley ThomasDirector
|
GrantOption to purchase common stock · Derivative | 35,000 | $0.00 Strike: $8.77 | $0.00 |
DisclosureSEC source: 0001193125-26-257896 · ownership.xml · derivative · entry 1 Malley Thomas · CIK 0001403322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2036-06-03 F1 · derivative.exercise_date: This option vests in full on the one year anniversary of the date of grant. Read SEC document |
| May 21, 2026 Filed May 22, 2026 20:05 UTC |
Powl Brian T.Chief Commercial Officer
|
SaleCommon Stock | 10,000 | $11.00 | $110,000.00 |
DisclosureSEC source: 0001193125-26-236838 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 173,614 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:05 UTC |
Powl Brian T.Chief Commercial Officer
|
SaleCommon Stock | 339 | $9.21 | $3,122.19 |
DisclosureSEC source: 0001193125-26-232547 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 183,614 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 18, 2025. F2 · shares: 678 shares were acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| May 19, 2026 Filed May 20, 2026 20:05 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 2,257 | $9.08 | $20,482.73 |
DisclosureSEC source: 0001193125-26-232548 · ownership.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,560 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 29, 2025. F2 · shares: 2,257 shares were acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $8.97 to $9.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 18, 2026 Filed May 20, 2026 20:05 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 2,256 | $9.38 | $21,160.15 |
DisclosureSEC source: 0001193125-26-232546 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,931 F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 4, 2025. F2 · shares: 2,256 shares were acquired on May 17, 2026 pursuant to the Issuer's Employee Stock Purchase Plan. F3 · price: This transaction was executed in multiple trades at prices ranging from $9.28 to $9.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 23, 2026 Filed Mar 25, 2026 13:00 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 6,103 | $0.00 Strike: $6.15 | $0.00 |
DisclosureSEC source: 0001193125-26-122938 · ownership.xml · derivative · entry 4 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,103 shares Expires 2027-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents stock options exercised. F2 · derivative.exercise_date: This option is fully vested. Read SEC document |
| March 23, 2026 Filed Mar 25, 2026 13:00 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
Exercise / conversionCommon Stock | 6,103 | $6.15 | $37,533.45 |
DisclosureSEC source: 0001193125-26-122938 · ownership.xml · nonDerivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 435,456 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents stock options exercised. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 13:00 UTC |
Malley ThomasDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.12 | $0.00 |
DisclosureSEC source: 0001193125-26-116834 · ownership.xml · derivative · entry 3 Malley Thomas · CIK 0001403322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,000 shares Expires 2026-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents stock options exercised. F3 · derivative.exercise_date: This option is fully vested. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 13:00 UTC |
Malley ThomasDirector
|
Exercise / conversionCommon Stock | 10,000 | $3.12 | $31,200.00 |
DisclosureSEC source: 0001193125-26-116834 · ownership.xml · nonDerivative · entry 1 Malley Thomas · CIK 0001403322 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Represents stock options exercised. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 1,341 | $8.46 | $11,345.80 |
DisclosureSEC source: 0001193125-26-025303 · ownership.xml · nonDerivative · entry 4 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,274 F4 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 951 | $8.46 | $8,046.13 |
DisclosureSEC source: 0001193125-26-025303 · ownership.xml · nonDerivative · entry 3 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 268,615 F3 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 2,233 | $8.46 | $18,892.74 |
DisclosureSEC source: 0001193125-26-025303 · ownership.xml · nonDerivative · entry 2 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,566 F2 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/24. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
Leoni MollieChief Medical Officer
|
SaleCommon Stock | 3,655 | $8.46 | $30,923.86 |
DisclosureSEC source: 0001193125-26-025303 · ownership.xml · nonDerivative · entry 1 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,799 F1 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25. Read SEC document |
| January 27, 2026 Filed Jan 27, 2026 21:35 UTC |
Burrows FrancisChief Scientific Officer
|
SaleCommon Stock | 1,311 | $8.46 | $11,091.98 |
DisclosureSEC source: 0001193125-26-025306 · ownership.xml · nonDerivative · entry 1 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,424 F1 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 4,777 | $8.46 | $40,416.76 |
DisclosureSEC source: 0001193125-26-025301 · ownership.xml · nonDerivative · entry 3 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,931 F3 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 2,335 | $8.46 | $19,755.73 |
DisclosureSEC source: 0001193125-26-025301 · ownership.xml · nonDerivative · entry 2 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,708 F2 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
Bair Teresa BrophyChief Legal Officer
|
SaleCommon Stock | 4,096 | $8.46 | $34,655.03 |
DisclosureSEC source: 0001193125-26-025301 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 234,043 F1 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
FORD KATHLEENChief Operating Officer
|
SaleCommon Stock | 1,813 | $8.46 | $15,339.25 |
DisclosureSEC source: 0001193125-26-025304 · ownership.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,560 F1 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
Powl Brian T.Chief Commercial Officer
|
SaleCommon Stock | 1,572 | $8.46 | $13,300.22 |
DisclosureSEC source: 0001193125-26-025305 · ownership.xml · nonDerivative · entry 2 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 183,275 F2 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
Powl Brian T.Chief Commercial Officer
|
SaleCommon Stock | 4,842 | $8.46 | $40,966.23 |
DisclosureSEC source: 0001193125-26-025305 · ownership.xml · nonDerivative · entry 1 Powl Brian T. · CIK 0001934232 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 184,847 F1 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 881 | $8.46 | $7,453.88 |
DisclosureSEC source: 0001193125-26-025302 · ownership.xml · nonDerivative · entry 5 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 145,167 F5 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 2,226 | $8.46 | $18,833.52 |
DisclosureSEC source: 0001193125-26-025302 · ownership.xml · nonDerivative · entry 4 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 146,048 F4 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/25. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 695 | $8.46 | $5,880.19 |
DisclosureSEC source: 0001193125-26-025302 · ownership.xml · nonDerivative · entry 3 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,274 F3 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 1,114 | $8.46 | $9,425.22 |
DisclosureSEC source: 0001193125-26-025302 · ownership.xml · nonDerivative · entry 2 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,969 F2 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23. Read SEC document |
| January 27, 2026 Filed Jan 28, 2026 02:35 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
SaleCommon Stock | 2,226 | $8.46 | $18,833.52 |
DisclosureSEC source: 0001193125-26-025302 · ownership.xml · nonDerivative · entry 1 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,083 F1 · acquired: Sell-to-cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/2/24. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
Leoni MollieChief Medical Officer
|
GrantOption to purchase common stock · Derivative | 100,000 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004570 · ownership.xml · derivative · entry 2 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-01-01 F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
Leoni MollieChief Medical Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-004570 · ownership.xml · nonDerivative · entry 1 Leoni Mollie · CIK 0002051106 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 275,454 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 16:30 UTC |
Burrows FrancisChief Scientific Officer
|
GrantOption to purchase common stock · Derivative | 185,000 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004566 · ownership.xml · derivative · entry 1 Burrows Francis · CIK 0002051119 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 185,000 Underlying: Common Stock · 185,000 shares Expires 2036-01-01 F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
Bair Teresa BrophyChief Legal Officer
|
GrantOption to purchase common stock · Derivative | 100,000 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004562 · ownership.xml · derivative · entry 2 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-01-01 F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
Bair Teresa BrophyChief Legal Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-004562 · ownership.xml · nonDerivative · entry 1 Bair Teresa Brophy · CIK 0001813058 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 238,139 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:31 UTC |
WILSON TROY EDWARDDirector · President and CEO
|
GrantOption to purchase common stock · Derivative | 1,120,000 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004580 · ownership.xml · derivative · entry 1 WILSON TROY EDWARD · CIK 0001589597 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,120,000 Underlying: Common Stock · 1,120,000 shares Expires 2036-01-01 F1 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
GrantOption to purchase common stock · Derivative | 42,500 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004569 · ownership.xml · derivative · entry 3 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,500 Underlying: Common Stock · 42,500 shares Expires 2036-01-01 F3 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
DOYLE THOMAS JAMESSVP, Finance & Accounting
|
GrantCommon Stock | 21,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-004569 · ownership.xml · nonDerivative · entry 1 DOYLE THOMAS JAMES · CIK 0001910331 · SVP, Finance & Accounting 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,309 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30. F2 · balance_after: Includes 802 shares acquired on November 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
FORD KATHLEENChief Operating Officer
|
GrantOption to purchase common stock · Derivative | 100,000 | $0.00 Strike: $10.34 | $0.00 |
DisclosureSEC source: 0001193125-26-004567 · ownership.xml · derivative · entry 2 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-01-01 F2 · derivative.exercise_date: This option vests in 48 equal monthly installments commencing on the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 21:30 UTC |
FORD KATHLEENChief Operating Officer
|
GrantCommon Stock | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-004567 · ownership.xml · nonDerivative · entry 1 FORD KATHLEEN · CIK 0001785406 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 155,373 F1 · shares: Grant of Restricted Stock Units (RSUs). The RSUs vest in four equal annual installments on 1/26/27, 1/26/28, 1/26/29 and 1/26/30. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.